Organto Foods (OGO) investor relations material

Executive summary

• Achieved record sales of CAD 27.7 million ($27.7 million) in Q2 2026, up 61% year-over-year, and record gross profit of CAD 2.1 million ($2.1 million), up 65% year-over-year, driven by both new and existing customers.

• Year-to-date sales reached CAD 53.3 million, up 73%, tracking above a CAD 100 million annualized run rate.

• EBITDA improved to CAD 400,000 ($0.4 million) in Q2, a turnaround from negative EBITDA in the prior year.

• Working capital increased to CAD 15.3 million ($15.3 million), with no long-term debt and equity up 87% since year-end to CAD 16.4 million ($16.4 million).

• Expanded into new markets (Switzerland, Spain, Ukraine), added eight new European retailers, and strengthened leadership and organizational structure.

Financial highlights

• Gross profit margin reached 7.5% in Q2 and 7.3% year-to-date; adjusted gross profit (including currency hedging) was $2.2 million (7.8% margin).

• Cash operating costs as a percentage of sales declined to 6.3% in Q2 from 6.8% prior year.

• Cash position at quarter-end was CAD 5.4 million ($5.4 million), plus CAD 1 million in restricted cash.

• Rabobank funding facility expanded from EUR 4 million to EUR 7 million.

• Net loss from continuing operations narrowed to $0.1 million from $7.2 million in Q2 2025, which included significant one-time restructuring costs.

Outlook and guidance

• Focus remains on scaling the European Fresh platform, expanding into North America, and building a world-class organic and fairtrade foods company.

• Continued emphasis on margin management, operating leverage, and sustainable, profitable growth.

• Strategic expansion through M&A and new product categories, including value-added and non-fresh products.

• No specific guidance provided, but positive EBITDA trend and annualized sales run rate above $100 million expected to continue.